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Introduction: Acute kidney injury (AKI) occurs frequently after liver transplantation and is associated with significant
morbidity and mortality. Recent evidence has linked the predominant usage of ‘chloride-liberal’ intravenous fluids,
such as 0.9% saline to the development of renal dysfunction in general critically ill patients. We compared the
effects of perioperative fluid types on AKI in liver transplant recipients.
Methods: An observational analysis of liver transplant recipients over a 33-month period, between January
2010 and September 2013, was performed. Intensive care unit database and patient records were analyzed for
determinants of early postoperative AKI. Univariate and multivariate regression analysis was carried out using a
two-tailed P value less than 0.05 to establish significance. The institutional Research Ethics Committee approved
the study methodology (RAC no. 2131 073).
Results: One hundred and fifty-eight liver transplants were performed, AKI developed in 57 (36.1%) patients: 39
(68.4%) fully recovered, 13 (22.8%) developed chronic renal failure and 10 (17.5%) required long-term hemodialysis.
On univariate regression analysis, AKI was significantly associated with greater than 3,200 ml of chloride-liberal
fluids infused within the first postoperative day (HR 5.9, 95% CI 2.64, 13.2, P <0.001), greater than 1,500 ml colloids
received in the operating room (hazard ratio (HR) 1.97, 95% CI 1.01, 3.8, P = 0.046), vasopressor requirement for 48
hours posttransplant (HR 3.34, 95% CI 1.55, 7.21, P = 0.002), hyperchloremia at day 2 (HR 1.09, 95% CI 1.01, 1.18,
P = 0.015) and preoperative model for end-stage liver disease (MELD) score (HR 1.08, 95% CI 1.03, 1.13, P <0.001).
After stepwise multivariate regression, infusion of greater than 3,200 ml of chloride-liberal fluids (HR 6.25, 95%
CI 2.69, 14.5, P <0.000) and preoperative MELD score (HR 1.08, 95% CI 1.02, 1.15, P = 0.004) remained significant
predictors for AKI.
Conclusions: In a sample of liver transplant recipients, infusion of higher volumes of chloride-liberal fluids and
preoperative status was associated with an increased risk for postoperative AKI.Introduction
Acute kidney injury (AKI) occurs both frequently after
liver transplantation, reportedly in 29 to 60% recipients
[1-3] and, irrespective of severity, confers an increased
risk of death [4]. This increase in risk of mortality
extends from the early postoperative period (28 days) and
up to one year after transplantation [1]. The National
Institute of Diabetes and Digestive and Kidney Disease
(NIDDK) long-term follow-up study ascribed a 2.66 hazard* Correspondence: salahuddin.nawal@gmail.com
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unless otherwise stated.ratio (HR) directly attributable to renal dysfunction
developing after liver transplantation [5].
Previously described risk factors for AKI in liver recipients
are greater severity of illness pretransplant (higher model
for end-stage liver disease (MELD) scores, intensive care
unit (ICU) admission, and coagulopathy), vasopressors, and
greater transfusions in the immediate perioperative period
[5-13]. However, very little is known about the effects
of intravenous fluid selection (chloride-liberal versus
chloride-restrictive) or the effects of fluid balance on
the risk of renal injury. An overall fluid overload state
leads to renal congestion, compromised renal blood flow
and reductions in glomerular filtration rate (GFR) [14].
In critically ill patients, a positive fluid balance has beenl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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outcomes once AKI develops [17-19]. Recent evidence
has highlighted the possible nephrotoxic effects of
‘chloride-liberal’ fluids (0.9% saline). Animal and human
controlled studies have shown that infusions of chloride-
liberal or solutions with supraphysiological chloride
concentrations cause vasoconstriction of renal afferent
arterioles, cortical hypoperfusion and decreased GFR
[20-22]. In a recent pre- and postintervention study,
restriction to chloride-restrictive fluids was associated
with lower AKI and need for renal replacement therapy
(RRT) as compared to chloride-liberal fluids [23]. Therefore,
perioperative intravenous fluid selection and volume may
prove to be a modifiable risk factor for the prevention of
AKI. No similar data exists for liver transplant recipients.
These patients clearly are at an increased risk of renal
injury with mortal consequences. We hypothesized
that AKI occurring in the early postoperative period
after liver transplant may be associated with the use of
chloride-liberal fluids and overall fluid overload causing
renal congestion.
Material and methods
This study is reported following the STROBE statement
checklist for observational studies [24]. All studies at our
institution require ethical approval; the Office of Research
Affairs (ORA) and ORA Research Ethics Committee
approved the study (RAC no. 2131 073). Patient consent
was waived by the Research Ethics Committee.
Study design and setting
This was an observational study of liver transplant
recipients carried out at a tertiary care, university
hospital over a 33-month period between January 2010
and September 2013.
Operational definitions
AKI was defined according to the risk, injury, failure,
loss, end-stage renal failure (RIFLE) classification [25]
of renal dysfunction, that is using both increases in
creatinine from preoperative values and urine output
measured as urine volume in milliliters/patient’s baseline
weight in kilograms/hour. Serum creatinine values were
measured preoperatively and daily for up to the third
postoperative day. Serum creatinine was measured
using the COBAS Integra Creatinine plus ver. 2 assay
(Roche Diagnostics Corp, Basel, Switzerland). This is an
enzymatic method based on the determination of hydro-
gen peroxide after conversion of creatinine with the aid of
creatininase, creatinase, and sarcosine oxidase. Patients
were screened for the development of postoperative AKI
on a daily basis until the third day.
Prolonged ICU stay was defined a priori as a cutoff
value of the mean (or median for skewed data) ICU daysafter transplantation. Delayed weaning from mechanical
ventilation was defined as <3 > days of invasive ventilation.
Chloride-liberal fluids were fluids containing supra-
physiological concentrations of chloride (0.9% saline,
20% and 5% albumin); chloride-restrictive fluids were fluids
with chloride concentrations closer to plasma (0.45% saline,
Ringer’s lactate).
Participants
Consecutive adult liver transplant recipients within the
specified study period were included. Patients undergoing
multiorgan transplantation were excluded.
Crystalloids used in the study patients were: lactated
Ringer’s (sodium chloride, potassium chloride, sodium
lactate and calcium chloride) injection, 0.9% sodium
chloride injection, USP, 0.45% sodium chloride injection,
USP, manufactured by Baxter Healthcare Corp, Deerfield
IL, USA. Colloids used were: human albumin 5% and
20% manufactured by Biotest Pharma GmbH, Dreieich,
Germany.
Variables
The primary outcome variable was the development
of postoperative AKI. Other outcome variables studied
were delayed weaning from mechanical ventilation,
prolonged ICU stay (as defined above), ICU mortality,
and 28-day mortality. Other variables collected were
recipient demographic data, etiology of cirrhosis, comorbid-
ities, posttransplant acute physiologic and chronic health
evaluation II (APACHE II) scores, routine hematological,
biochemical and organ dysfunction/physiological (AKI,
vasopressors, RRT, mechanical ventilation) data, fluid
balance, fluids and blood products received at admission
to ICU and daily up to day 3 posttransplantation.
Data sources/measurement
In our ICU, patient data is routinely entered into an ICU
database. Data entry is by a critical care nurse dedicated
to the database. Patient data required for the study and
missing from the database was extracted by the research
team (AH, HS, BB, AN) from the patient’s electronic
medical records and laboratory computerized results.
Statistical analysis
Continuous data was tested for normality: measures of
central tendency were compared as means ± standard
deviations (SD) using the Student’s t test for normally
distributed variables and as medians (interquartile range,
IQR) using the Mann-Whitney U test for skewed data.
Categorical variables were compared using the chi-square
test or the Fisher exact test for n <5. Fluid volumes were
dealt with as continuous variables while fluid types were
classified into either ‘chloride-liberal’ or ‘chloride-restrictive’
and correspondingly dealt with as continuous variables.
Nadeem et al. Critical Care 2014, 18:625 Page 3 of 8
http://ccforum.com/content/18/6/625Logistic regression analysis was performed to determine
the predictive ability of variables for AKI, prolonged ICU
stay and prolonged mechanical ventilation. Univariate and
multivariate techniques were used, and for multivariate re-
gression, a backward mode with a threshold 0.15 was used
for elimination. Multivariate associations were reported as
odds ratios (OR) with 95% confidence intervals (CIs). A
two-sided P value of <0.05 was considered as statistically
significant. All analyses were carried out using IBM SPSS
version 22.0 (IBM Corp, Armonk, NY, USA).
Results
Participants and descriptive data
One hundred and fifty-eight liver transplants were per-
formed during the study period. Of these, 104 (65.8%) were
living donor-related transplants, 53 (33.5%) cadaveric and 1
(0.6%) was a retransplant. Mean age of transplant recipients
was 52.3 ± 13.3 years and 66 (42%) were female, mean body
mass index (BMI) was 26.8 ± 6 (range 14, 49). Mean MELD
score at time of transplantation was 19.4 ± 7.7 (range 6, 45),
with mean baseline creatinine 88.7 micromol/L ± 56 (range
27, 350). Transplant recipients had end-stage liver disease
caused by: hepatitis C in 60 (38%) patients, hepatitis
B in 34 (21.5%), cryptogenic liver disease in 41 (25.9%),
autoimmune disease in 9 (5.7%) and others (bilharziasis,
congenital hepatic cirrhosis, Budd-Chiari, Wilson’s
disease) in 14 (9%) recipients. Fifty-two (32.9%) patients
had hepatocellular carcinomas.
All patients were transferred to the ICU posttransplant.
On arrival, transplant recipients were in a positive
fluid balance of 8.48 ± 2.3 liters fluid, having received
1.7 ± 0.26 L packed red cells, 3.8 ± 0.143 L blood
products (plasma, cryoprecipitate, platelets) and a
mean of 7.8 ± 6.3 L crystalloids of which 5.6 ± 4.0 L were
chloride-liberal and 2.4 ± 1.4 L were chloride-restrictive
fluids. Mean APACHE II score was 15.9 ± 5.4 (range 4,
48), serum procalcitonin level 2.4 ngm/ml (IQR 3.1),
proBNP 476 pg/mL (IQR 2,510) and 120 (76%) patients
were on a norepinephrine infusion. Seventy-eight (49.4%)
had pleural effusions; pleural drainage by pigtail catheters
was carried out in 23 out of 78 patients (29.4%). In
the first 72 hours of ICU stay, transplant recipients were
in a cumulative positive fluid balance of 12.7 ± 7.8 L with
9 ± 6 L crystalloids, 6.4 ± 3.5 L colloids (5%, 20% albumin)
and 25 ± 11.9 L chloride-liberal (0.9% saline, 5% albumin,
20% albumin) received. Blood products transfused
were 4 L (IQR 4.8). There was no significant difference
between the mean serum chloride levels in the
chloride-liberal group compared to the chloride-restrictive
group, 114 ± 5.8 versus 113 ± 5.9, P >0.05. No signifi-
cant correlation was found between the mean serum
chloride concentrations and the cumulative volumes
of chloride-liberal fluids given, P >0.05 (see Table 1
and Figure 1).Median ICU length of stay was five days (IQR 6), mean
8.4 ± 12.5 days. Patients were ventilated for a median of
two days (IQR 2) with nine (5.7%) patients subsequently
undergoing tracheostomy. ICU mortality was 8.2% (13
patients); 28-day survival was 140 (88.6%). Eight (5%)
recipients were readmitted to the ICU for the following:
respiratory failure two, sepsis three, bleeding three. Mean
time to readmission was 3.5 ± 1.1 days (2, 5).
Outcomes
AKI developed in 58 (36.4%) patients; classified as risk
in 30 (52%), injury in 12 (21%) and failure in 16 (27%)
patients. Ninety percent (53 patients) developed AKI
within the first two postoperative days. All liver
transplant patients, both the group that developed
AKI and those that did not were on the calcineurin
inhibitor, tacrolimus. Drug levels were routinely monitored
and dosing adjusted accordingly. Thirty-nine (68.4%)
patients recovered fully, 13 (22.8%) developed chronic
renal failure and 10 (17.5%) required long-term hemodialysis.
AKI was significantly associated with ICU mortality,
P = 0.001 and 28-day mortality, P <0.001. Mean serum
chloride levels on the second postoperative day were
significantly greater in patients who developed AKI com-
pared to those who did not; 114 ± 7.2 versus 112 ± 4.4,
P = 0.01. The mean chloride levels on days one and
three were not significantly different. There were no
significant associations between mean serum chloride
levels and the severity of renal failure (see Table 2).
Univariate outcome data
On univariate regression analysis, AKI was significantly
associated with greater than 3,200 ml of chloride-liberal
fluids infused within the first postoperative day (HR 5.9,
95% CI 2.64, 13.2, P <0.001), greater than 1,500 ml
colloids received in the OR (HR 1.97, 95% CI 1.01,
3.8, P = 0.046), vasopressor requirement for 48 hours
posttransplant (HR 3.34, 95% CI 1.55, 7.21, P = 0.002),
hyperchloremia at day 2 (HR 1.09, 95% CI 1.01, 1.18,
P = 0.015) and preoperative MELD score (HR 1.08, 95%
CI 1.03, 1.13, P = 0.001).
Delayed weaning from mechanical ventilation was
associated with higher volumes of chloride-liberal
fluids, P = 0.02, higher colloid volumes, P = 0.015, blood
products transfused, P = 0.017 and a cumulative positive
fluid balance, P = 0.026. Higher pretransplant MELD
scores, P = 0.001, male gender, P = 0.015, transplant for
hepatocellular carcinoma, P = 0.014, crystalloid volume
received in the first 72 hours, P = 0.034, need for vasopres-
sors at 48 hours, P <0.001 and 72 hours, P = 0.031, AKI,
P <0.001 and pleural effusion, P = 0.001 were significantly
associated with a prolonged ICU admission. Drainage of
effusion was significantly associated with a reduced ICU
stay, P = 0.007 (see Tables 3 and 4).
Table 1 Chemical compositions of fluids used in liver transplant recipients
Fluid-type Composition per 1 liter Manufacturer
crystalloids
0.9% Sodium chloride, USP 154 mEq Sodium Baxter Healthcare Corp, Deerfield, IL, USA
154 mEq Chloride
0.45% Sodium chloride, USP 77 mEq Sodium Baxter Healthcare Corp, Deerfield, IL, USA
77 mEq Chloride




28 mEq Sodium lactate
Colloids
Human albumin 5% biotest Plasma protein 50gm (96% albumin), caprylate (4 mmol/l),
N-acetyl-DL-tryptophanate (4 mmol/l), sodium ions (145 mmol/l),
water for injections ad 1,000 ml
Biotest Pharma GmbH
Dreieich, Germany
Human albumin 20% biotest
(given diluted in 0.9% normal saline)
200 g/l (at least 95% is human albumin) Biotest Pharma GmbH
Dreieich, Germany
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After adjusting for covariates, infusion of greater than
3,200 ml of chloride-liberal fluids (HR 6.25, 95% CI 2.69,
14.5, P <0.001) and preoperative MELD score (HR 1.08,
95% CI 1.02, 1.15, P = 0.004) remained significant predictors
for AKI. Prolonged ICU stay was predicted by male gender,
P = 0.014, vasopressors = 0.003 and the development of
AKI, P = 0.013 (see Table 5).Figure 1 Relative volumes of chloride-liberal fluids received by liver tDiscussion
In this observational study, we found that liver transplant
recipients were more likely to develop AKI if they received
larger volumes of chloride-liberal (hyperchloremic) fluids.
This association was significant, after adjusting for
baseline variables, for both 5% albumin in 0.9% saline
and only 0.9% saline infusions. Patients who devel-
oped AKI had significantly higher serum chlorideransplant recipients with and without acute kidney injury (AKI).
Table 2 Characteristics of liver transplant patients







Age, years 51 ± 14.2 54 ± 11.3 0.13
BMI 26.4 ± 6 27.7 ± 6.6 0.19
Pretransplant creatinine,
micromol/L
76.2 ± 40.2 110.8 ± 72.6 0.001
Pretransplant MELD score 19.2 ± 5.4 21.8 ± 9.1 0.001
Volume of chloride-liberal fluids,
liters (IQR)
Operating room 4.7 (5.7) 6 (6.8) 0.23
24 hours 2.1 (1.2) 3.8 (2.7) <0.001
48 hours 0.64 (1.06) 1.7 (1.5) 0.007
72 hours 0.35 (0.65) 1.07 (0.87) 0.55
Volume of chloride-restrictive
fluids, liters (IQR)
Operating room 2 (2) 2 (1.2) 0.46
24 hours 1.9 (1.28) 1.8 (1.4) 0.32
48 hours 2.0 (0.76) 1.9 (1.6) 0.86
72 hours 1.3 (1.0) 1.6 (1.1) 0.67
Volume of colloids, liters (IQR)
Operating room 1.5 (1) 2.1 (2.5) 0.013
24 hours posttransplant 1.2 (1.03) 1.9 (1.4) 0.001
48 hours posttransplant 0.45 (0.85) 0.95 (0.71) 0.016
72 hours posttransplant 0.35 (0.65) 1.0 (0.87) 0.05
Volume of packed RBC
transfusions, liters (IQR)
Operating room 1.5 (1.2) 2.2 (1.9) 0.022
24 hours 0.76 (0.44) 1.14 (5.8) 0.19
48 hours 0.53 (0.38) 0.72 (0.53) 0.08
72 hours 0.38 (0.71) 0.38 (0.06) 0.89
Volume of blood products
transfused, liters (IQR)
Operating room 3.2 (2.3) 3.8 (3.2) 0.17
24 hours 0.95 (2.1) 2.1 (4.8) 0.14
48 hours posttransplant 0.72 (0.53) 0.97 (1.2) 0.63
72 hours posttransplant 0.63 (1.5) 0.51 (0.32) 0.78
Volume of crystalloids
infused, liters (IQR)
Operating room 6 (5.6) 6 (6) 0.8
24 hours 2.5 (1.3) 3.1 (1.9) 0.15
48 hours 2.1 (0.72) 2.4 (1.4) 0.22
72 hours 1.6 (0.96) 1.7 (1.1) 0.30
Fluid balance, liters (IQR)
Operating room 6.4 (4.7) 6.7 (5.4) 0.76
24 hours 2.9 (2.6) 3.7 (4.8) 0.09
Table 2 Characteristics of liver transplant patients
grouped by acute kidney injury according to the RIFLE
classification (Continued)
48 hours 1.6 (1.5) 1.7 (2.4) 0.06
72 hours 0.947 (2.07) 0.623 (1.54) 0.93
Serum lactate, mmol/L
Day 1 4.2 ± 2.9 4.8 ± 3.9 0.26
Day 2 1.8 ± 1.1 2.1 ± 1.6 0.09
Day 3 1.4 ± 0.5 1.9 ± 0.3 0.046
Serum sodium, mmol/L
Day 1 146 ± 5.2 146.5 ± 5.0 0.57
Day 2 143 ± 5.7 145 ± 3 0.016
Day 3 144 ± 2.3 146 ± 2.6 0.002
Serum chloride, mmol/L
Day 1 114 ± 5.7 113 ± 5.9 0.76
Day 2 112 ± 4.4 114 ± 7.2 0.01
Day 3 110 ± 4.6 111 ± 4.8 0.18
Vasopressor requirement
At admission 73 (72%) 47 (82.5%) 0.25
Day 1 3 (3%) 1 (1.8%) 0.64
Day 2 15 (14.8%) 21 (36.8%) 0.002
Day 3 4 (4%) 8 (14%) 0.056
Days on mechanical ventilation 2.3 ± 3.6 6 ± 7.1 0.001
Length of ICU stay after transplant 5.5 ± 4.7 13.4 ± 19 0.003
AKI, acute kidney injury; BMI, body mass index; ICU, intensive care unit; IQR,
interquartile range; MELD, model for end-stage liver disease; RIFLE, risk, injury,
failure, loss, end-stage renal failure.
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develop AKI.
‘Normal’ saline or 0.9% saline contains supraphysiological
levels of chloride (154 mmol/L as compared to Hartmann’s
solution, Ringer’s lactate or Plasma-Lyte 148, all of
which contain chloride concentrations that are lower
(94 to 111 mmol/L). Five percent albumin is available
either as salt-poor or in sodium chloride (chloride
concentration 128 mmol/L). Intravenous infusions of
chloride-liberal fluids have been associated with hyper-
chloremia and metabolic acidosis when administered in
large volumes [26].
Our results show a detrimental effect on renal function
with use of chloride-liberal fluids in the immediate
postoperative period (up to 48 hours). Support for our
findings comes from animal studies that have demonstrated
reductions in GFRs, renal arteriolar vasoconstriction [27],
and human volunteer studies that have shown reduced
renal cortical tissue perfusion, renal blood flow velocity
after infusions of hyperchloremic solutions. [28]. In
controlled trials, chloride-liberal fluids compared to
chloride-poor fluids have been linked to longer time to
micturition [21], lower urine output [29] and in a recent
Table 3 Demographic, fluids and outcome variables in
liver transplant patients grouped by ICU length of stay
<5 days ICU
stay (n = 78)
≥5 days ICU
stay (n = 80)
P value
Male gender 25 (32%) 41 (51.2%) 0.015
HCC 33 (42.3%) 19 (23.1.7%) 0.014
Pretransplant MELD score 17 ± 5.9 21.3 ± 8 0.001
Volume of crystalloids
received by 72 hours ml (IQR)
1,675 (1,055) 1,520 (1,066) 0.034
Volume of colloids received
by ml (IQR)
24 hours posttransplant 1,247 (1,263) 1,700 (1,188) 0.046
48 hours posttransplant 650 (713) 950 (1095) 0.015
Undrained pleural effusion
posttransplant
28 (35.8%) 50 (62.5%) 0.001
Vasopressors requirement
48 hours posttransplant 8 (10.3%) 28 (35%) 0.001
72 hours posttransplant 2 (2.6%) 10 (12.5%) 0.031
AKI 17 (22%) 40 (50%) <0.001
Early complications 43 (55.1%) 50 (62.5%) 0.035
AKI, acute kidney injury; HCC, hepatocellular carcinoma; ICU, intensive care
unit; IQR, interquartile range; MELD, model for end-stage liver disease.
Table 5 Regression analysis for variables associated with
acute kidney injury post-liver transplantation
Hazard
ratio
95% CI P value
Univariate analysis
MELD score 1.08 1.03,1013 0.001
APACHE II score at admission to ICU 1.08 1.03,1.15 0.018
Colloids ≥1,500 ml received in OR 1.97 1.01,3.8 0.046
Chloride-liberal fluids ≥3,200 ml received
within the first 24 hours posttransplant
5.9 2.64,13.2 0.000
Vasopressors requirement at 2 days
posttransplant
3.34 1.55,7.21 0.002
Serum chloride level at day 2 1.09 1.01,1.18 0.015
Multivariate analysis
Chloride-liberal fluids ≥3,200 ml received
within the first 24 hours posttransplant
6.25 2.69,14.5 <0.001
Preoperative MELD score 1.08 1.02,1.15 0.004
APACHE II, acute physiology and chronic health evaluation II; CI, confidence
interval; ICU, intensive care unit; MELD, model for end-stage liver disease; OR,
operating room.
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0.9% saline compared to ‘balanced’ crystalloids increased
the risk of acute renal failure requiring dialysis [30].
Yunos et al., in a pre- and postintervention study on 1,530
critically ill patients found that a chloride-restrictive fluidTable 4 Perioperative fluids in patients after liver transplant










Volume of blood products,* ml (IQR)
Operating room 4,030 (2391) 5,321 (4607) 0.015
24 hours posttransplant 920 (1551) 3,028 (3893) 0.017
48 hours posttransplant 415 (470) 827 (1194) 0.048
Volume of colloids, ml (IQR)
Operating room 1,500 (1875) 2,421 (850) 0.032
24 hours posttransplant 1,842 (1019) 2,315 (1205) <0.001
48 hours posttransplant 625 (669) 1,193 (933) <0.001
72 hours posttransplant 675 (881) 700 (883) 0.015
Volume of chloride-liberal
fluids, ml (IQR)
Operating room 5,000 (7813) 7,000 (8434) 0.027
24 hours posttransplant 3,397 (2868) 3,725 (2473) 0.020
Fluid balance at 48 hours
posttransplant, ml
1,725 (1186) 2,257 (2102) 0.026
*Includes packed cells, fresh frozen plasma, platelets, cryoprecipitate. IQR,
interquartile range.strategy resulted in a significant reduction in AKI, need
for RRT and increase in creatinine as compared to a
control group given chloride-liberal fluids [23].
Possible explanations for this renal ‘toxicity’ of chloride-
liberal fluids come from animal studies that have demon-
strated renal vasoconstriction [22] and thromboxane release
after chloride infusions [20]. Chloride infusions increase
delivery to the macula densa that stimulates glomerulotub-
ular feedback leading to afferent arteriole constriction,
mesangial contraction and resultant decrease in GFR [31].
Patients in our study received both 5% albumin in saline
and 20% albumin in saline. Though it is possible that the
observed renal dysfunction resulted from hyperoncotic
albumin, the data on 20% albumin is so far inconclusive. A
recent cohort study on 1,000 patients found a higher risk
of renal injury and failure with the use of hyperoncotic
albumin (OR 5.99) [32], however, a contradictory result
was reported from two meta-analyses that concluded no
harmful effects of hyperoncotic resuscitation [33,34]. The
SAFE study that compared albumin and saline found no
difference in adverse outcomes [35].
Fluid overload leads to organ dysfunction due to intersti-
tial edema and visceromegaly. The limited accommodative
capacity of the encapsulated kidney causes increased inter-
stitial hydrostatic pressures with reduced renal perfusion
and filtration [36]. Additionally, a fluid overload state
contributes to third spacing, ascitic fluid accumulation
and abdominal compartment syndrome [37]. Cumulative
fluid overload has been linked to poor outcomes in all
groups (pediatric, septic, postoperative) of critically ill
patients with prolonged days on mechanical ventilation,
ICU stay and mortality [16,17,38-43]. Recovery of renal
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fluid balance [17,38,42]. In our study, a cumulative
positive fluid balance increased the duration of stay in ICU.
A limitation of our study is that the observational design
does not establish a causal relationship of hyperchloremic
fluid excess with the development of AKI in liver transplant
recipients. These associations may be subject to bias from
selection, confounding or random error. We attempted to
control for confounders by using regression analysis.
Another limitation is the external validity or generalizability
of our results to other liver transplant recipients since we
collected data only from a single institution.Conclusions
In summary, large infusions of chloride-liberal fluids
may predict a higher risk of AKI in liver transplant
recipients. Our findings support the hypothesis that
‘routine’ intravenous fluids may not be routine and in
themselves be associated with organ dysfunction. Our
results can be used to build hypotheses for further
controlled trials.Key messages
 Chloride-liberal fluids may cause renal dysfunction
 Large volumes (>3,200 ml) of chloride-liberal
fluids infused in the first 24 hours after liver
transplantation were associated with a higher
risk of AKI.
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